The Aspire 4540 provides entertainment enjoyment with high quality visuals and pleasurable surround sound.
BENEFITS
Mobile Performance
Built to empower, the new Aspire 4540 is the perfect mobile entertainment tool. The beautifully designed 14” chassis is light enough to carry it with you wherever you go while the combination of the latest AMD Turion™ 64 X2 dual-core mobile processors, up to 2GB of system memory and ample storage space will easily fulfill all your everyday computing needs.
AS4540 - 501G25Mn
Linpus™ Linux® , AMD Turion™ II dual-core mobile processor M500 (1 MB L2 cache, 2.20 GHz, DDR2 800 MHz), supporting AMD HyperTransport™ 3.0 technology; 14″ HD Acer CineCrystal™ LED-backlit TFT LCD; 16:9 aspect ratio; 1GB DDR2 ; 250GB HDD DVD SuperMulti Double Layer Drive ; Integrated Bluetooth; Integrated Wireless LAN 802.11b/g/Draft-N ; 5-in-1 Media Reader ; HDMI™ port with HDCP support Crystal Eye webcam with Acer PrimaLite™ technology
SPECIFICATIONS
Operating System
Processor & Chipset
Memory
HDD
Storage
Display
Graphics
Multimedia
Communication
I/O Interface
Security
Power Supply & Battery
Keyboard & Special Controls
Weight & Dimensions
Software
Warranty
Workers unions from France are not pleased with the transfer of military technology to Brazil recently agreed between Brazilian president Luiz Inácio Lula da Silva and his French counterpart Nicholas Sarkozy.
“There’s something which troubles us in this contract and is the fact that Brazil wants to have its own military air industry and that the agreement with Dassault, the French government and the Brazilian government includes the transfer of technology,” said Dominique Richard, a workers union leader from Dassault Aviation, France’s main aircraft manufacturer.
Dassault designed and builds the Rafale fighter-bomber which France is prepared to sell to Brazil.
On signing a major military hardware agreement with French president Sarkozy, Lula said he was inclined to choose the French fighter Rafale because France is prepared to transfer sensitive technology and would also allow them to be assembled in Brazil.
Brazilian Foreign Affairs minister Celso Amorim also revealed that France is prepared to authorize the sale of those aircrafts to other Latin American countries.
Meanwhile Brazil will continue to consider the French offer for the Rafale, together with Boeing’s F-18 Super Hornet and Sweden’s Saab, Gripen.
Union leader Richard told Brazilian daily Folha de S. Paulo that the agreement threatens Dassault Aviation jobs in France.
Brazilian Defense minister Nelson Jobim has repeatedly said that with French technology, Brazil plans to become the leading military hardware manufacturer in Latinamerica with the largest military-industrial complex in the region.
However from France, Dassault in an official statement denied that the military cooperation agreement reached between France and Brazil, which includes submarines and helicopters, would have a negative impact on French jobs.(by Newsroom)
The 2007 Nobel Prize in Physiology or Medicine goes Americans Mario Capecchi, Oliver Smithies and Briton Martin Evans won the 2007 Nobel Prize in medicine on Monday for their discoveries of principles for introducing specific gene modifications in mice by the use of embryonic stem cells.
This morning, Mario R. Capecchi, Martin J. Evans and Oliver Smithies were jointly awarded the Nobel Prize in Physiology or Medicine for their discoveries of “principles for introducing specific gene modifications in mice by the use of embryonic stem cells.”
The technology for homologous recombination in embryonic stem cells permits specific targeting of genes for disruption or modification in the resulting animal. Known as transgenic gene “knockouts” (and more recently, “knock-ins”), the methodology has allowed the study of specific processes in normal development, adult physiology, and numerous diseases. According to the Nobel press release, over 10,000 gene knockout mouse strains are now available, representing the manipulation of half of the total genes in mice.
The process, known as gene targeting, has been used to help study such diseases as cystic fibrosis, heart disease, diabetes and cancer.
In its citation, the award committee said that the use of gene targeting has shed light on embryonic development, aging and disease.
The medicine prize was the first of the six prestigious awards to be announced this year. The others are chemistry, physics, literature, peace and economics.
The prizes are handed out every year on Dec. 10, the anniversary of award founder Alfred Nobel’s death in 1896.
With gene targeting it is now possible to produce almost any type of DNA modification in the mouse genome, allowing scientists to establish the roles of individual genes in health and disease. Gene targeting has already produced more than five hundred different mouse models of human disorders, including cardiovascular and neuro-degenerative diseases, diabetes and cancer.